Showing results (11-20 of 47) with videos related to
Sort By:
Pageof 5
Journal of Substance Abuse Treatment|June 26, 2007
Reduction in heavy drinking as a treatment outcome in alcohol dependenceDavid R Gastfriend, James C Garbutt, Helen M Pettinati, et al.The Psychiatric Clinics of North America|September 2, 2022
Practical Technology for Expanding and Improving Substance Use Disorder Treatment: Telehealth, Remote Monitoring, and Digital Health InterventionsMary M Sweeney, August F Holtyn, Maxine L Stitzer, et al.Journal of Addictive Diseases|July 5, 2005
Determining service variations between and within ASAM levels of careHelen J Levine, Winston Turner, Sharon Reif, et al.Journal of Substance Abuse Treatment|April 6, 2015
Extended-Release Naltrexone for Alcohol and Opioid Problems in Missouri Parolees and ProbationersPaul Crits-Christoph, Christie Lundy, Mark Stringer, et al.Addiction (Abingdon, England)|November 27, 2008
Persistence with oral naltrexone for alcohol treatment: implications for health-care utilizationHenry R Kranzler, Judith J Stephenson, Leslie Montejano, et al.Drug and Alcohol Dependence|March 17, 2005
Prevalence of physical and sexual abuse among substance abuse patients and impact on treatment outcomesSandrine Pirard, Estee Sharon, Shimi K Kang, et al.Drug and Alcohol Dependence|November 15, 2011
Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose-effects and time-courseGeorge E Bigelow, Kenzie L Preston, John Schmittner, et al.Journal of Addiction Medicine|March 31, 2017
Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid DependencePaul H Earley, Jacqueline Zummo, Asli Memisoglu, et al.The American Journal on Addictions|February 15, 2011
Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexoneCharles P O'Brien, David R Gastfriend, Robert F Forman, et al.Alcoholism, Clinical and Experimental Research|January 31, 2006
Advances in the pharmacotherapy of alcoholism: challenging misconceptionsHenry R Kranzler, George Koob, David R Gastfriend, et al.Pageof 5